Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
1571 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.970 | 67 | 1999 | 2020 | |||||
Carcinogenesis
|
355 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.857 | 14 | 2003 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
183 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 13 | 2008 | 2019 | |||||
Colorectal Carcinoma
|
1186 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.923 | 13 | 1999 | 2020 | |||||
Carcinoma of lung
|
995 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.933 | 12 | 2010 | 2019 | |||||
Malignant neoplasm of lung
|
1000 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 11 | 2009 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
62 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2010 | 2018 | |||||
Malignant Neoplasms
|
1441 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2009 | 2019 | |||||
Non-Small Cell Lung Carcinoma
|
601 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.790 | 1.000 | 9 | 2002 | 2019 | |||||
Lung Neoplasms
|
39 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.080 | 0.875 | 8 | 2008 | 2016 | |||||
Adenocarcinoma
|
167 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.070 | 1.000 | 7 | 2012 | 2020 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2012 | 2019 | |||||
Neoplasm Metastasis
|
327 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2009 | 2016 | |||||
Malignant neoplasm of pancreas
|
238 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2003 | 2019 | |||||
Tumor Progression
|
72 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 0.800 | 5 | 2011 | 2017 | |||||
melanoma
|
352 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Pancreatic carcinoma
|
236 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.740 | 1.000 | 4 | 2003 | 2019 | |||||
Rhabdomyosarcoma
|
17 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 2010 | 2018 | |||||
Brain Neoplasms
|
85 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Immunologic Deficiency Syndromes
|
24 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2005 | 2016 | |||||
Organoid Nevus Phakomatosis
|
5 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.730 | 1.000 | 3 | 2012 | 2019 | |||||
Pancreatic intraepithelial neoplasia
|
11 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2007 | 2016 | |||||
Precancerous Conditions
|
18 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2010 | 2015 |